Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sonoma Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SNOA
Nasdaq
2834
https://sonomapharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
- Apr 9th, 2024 11:30 am
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
- Apr 4th, 2024 11:30 am
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
- Mar 28th, 2024 8:01 pm
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
- Mar 27th, 2024 11:30 am
Sonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- Feb 10th, 2024 2:44 pm
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
- Feb 8th, 2024 9:10 pm
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
- Jan 23rd, 2024 12:30 pm
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
- Jan 9th, 2024 2:15 pm
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
- Nov 13th, 2023 9:10 pm
Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
- Nov 3rd, 2023 11:30 am
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
- Oct 26th, 2023 1:10 pm
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
- Sep 21st, 2023 1:35 pm
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
- Aug 15th, 2023 11:30 am
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results
- Aug 10th, 2023 8:15 pm
Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board
- Aug 3rd, 2023 11:30 am
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results
- Jun 22nd, 2023 11:30 am
Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union
- Jun 8th, 2023 8:01 pm
Scroll